Once-Weekly Semaglutide in Adults with Overweight or Obesity REPLY

被引：0
作者：
Wilding, John P. H. [1 ]
Calanna, Salvatore [2 ]
Kushner, Robert F. [3 ]
机构：
[1] Univ Liverpool, Liverpool, Merseyside, England
[2] Novo Nordisk, Soborg, Denmark
[3] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2021年 / 385卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 3 条
[1]   Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, doubleblind, double-dummy, placebo-controlled, phase 3 trial [J].
Davies, Melanie ;
Faerch, Louise ;
Jeppesen, Ole K. ;
Pakseresht, Arash ;
Pedersen, Sue D. ;
Perreault, Leigh ;
Rosenstock, Julio ;
Shimomura, Iichiro ;
Viljoen, Adie ;
Wadden, Thomas A. ;
Lingvay, Ildiko .
LANCET, 2021, 397 (10278) :971-984
[2]   Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial [J].
O'Neil, Patrick M. ;
Birkenfeld, Andreas L. ;
McGowan, Barbara ;
Mosenzon, Ofri ;
Pedersen, Sue D. ;
Wharton, Sean ;
Carson, Charlotte Giwercman ;
Jepsen, Cecilie Heerdegen ;
Kabisch, Maria ;
Wilding, John P. H. .
LANCET, 2018, 392 (10148) :637-649
[3]   A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management [J].
Pi-Sunyer, Xavier ;
Astrup, Arne ;
Fujioka, Ken ;
Greenway, Frank ;
Halpern, Alfredo ;
Krempf, Michel ;
Lau, David C. W. ;
le Roux, Carel W. ;
Violante Ortiz, Rafael ;
Jensen, Christine Bjorn ;
Wilding, John P. H. .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (01) :11-22
1